LANDOS BIOPHARMA INC (LABP) Stock Income Statement
USA - NASDAQ:LABP - US5150692011 - Common Stock
22.93 USD
+0.13 (+0.58%)
22.91 USD
-0.02 (-0.09%)
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 18.00M | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 25.55M | 22.73M | 40.26M | 56.82M | 30.68M | |||
| Research and Development | 11.82M | 12.00M | 25.68M | 41.56M | 25.34M | |||
| Selling, General, and Administrative Expenses | 13.73M | 10.73M | 14.58M | 15.25M | 5.34M | |||
| Operating Income | -25.55M | -22.73M | -40.26M | -38.82M | -30.68M | |||
| Interest Income/Expense | -40.00K | -44.00K | 30.00K | -20.00K | 80.00K | |||
| Other Income/Expense | 789.00K | 836.00K | 1.26M | 410.00K | 460.00K | |||
| Non Recurring Items | null | null | -300.00K | null | null | |||
| Income Before Taxes | -24.80M | -21.93M | -39.28M | -38.42M | -30.14M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -24.80M | -21.93M | -39.28M | -38.42M | -30.14M | |||
| EBITDA | null | undefined | -39.68M | -38.62M | -30.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.98907 | -3.49514 | -9.76 | -10.23 | -7.51 | |||
| Non GAAP EPS | -3.9899999999999998 | -3.46 | -9.8 | null | null | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -213.44% | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | -215.67% | N/A | |||
All data in USD